Rajesh Gopalkrishna Pai

Rajesh Gopalkrishna Pai

Director Company Secretary DIN 06863732
DIN 06863732 First appointment May 2014 Primary industry Financial Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Gopalkrishna Pai

Data last updated:

Rajesh Gopalkrishna Pai was a Company Secretary at Icici Venture Funds Management Company Limited (2020–2022) and Nominee Director at I-Ven Biotech Limited (from 2014). The companies operate in Financial Services.

DIN 06863732
Primary Designation Company Secretary
Industry Financial Services
First Appointment 12 May 2014
Oldest Company Age 22 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Company Secretary16 Oct 20201988₹274 Cr (FY 2026)Active
I-Ven Biotech Limited U02421KA2003PLC033026
Nominee Director12 May 20142003₹3.4 Lakh (FY 2020)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
I-Ven Biotech Limited
Icici Venture Funds Management Company Limited
Premium access

Shareholding and investment profile for Rajesh Gopalkrishna Pai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Gopalkrishna Pai

Rajesh Gopalkrishna Pai was first appointed on 12 May 2014 as Nominee Director at I-Ven Biotech Limited. The most recent appointment on record is 16 Oct 2020 at Icici Venture Funds Management Company Limited.

Rajesh Gopalkrishna Pai held 2 earlier board appointments: Icici Venture Funds Management Company Limited (Company Secretary, 16 Oct 2020 to 02 Sep 2022); I-Ven Biotech Limited (Nominee Director, from 12 May 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available